🇺🇸 FDA
Patent

US 9763904

Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds

granted A61KA61K31/165A61K31/198

Quick answer

US patent 9763904 (Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/165, A61K31/198, A61K31/277, A61K9/2009